NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 315 filers reported holding NEOGENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $376,183 | -12.9% | 30,584 | +13.9% | 0.00% | 0.0% |
Q2 2023 | $431,656 | -48.3% | 26,861 | -44.0% | 0.00% | 0.0% |
Q1 2023 | $835,680 | +89.1% | 48,000 | +0.4% | 0.00% | 0.0% |
Q4 2022 | $441,940 | +7.0% | 47,829 | -0.2% | 0.00% | 0.0% |
Q3 2022 | $413,000 | -22.7% | 47,939 | -26.7% | 0.00% | 0.0% |
Q2 2022 | $534,000 | -44.0% | 65,427 | -16.7% | 0.00% | -50.0% |
Q1 2022 | $954,000 | -73.1% | 78,545 | -24.4% | 0.00% | -60.0% |
Q4 2021 | $3,544,000 | -33.3% | 103,870 | -5.6% | 0.01% | -44.4% |
Q3 2021 | $5,310,000 | -12.5% | 110,071 | -18.1% | 0.01% | -10.0% |
Q2 2021 | $6,069,000 | -0.9% | 134,361 | +5.8% | 0.01% | -9.1% |
Q1 2021 | $6,127,000 | +10.1% | 127,047 | +22.9% | 0.01% | 0.0% |
Q4 2020 | $5,563,000 | +57.1% | 103,337 | +7.7% | 0.01% | +37.5% |
Q3 2020 | $3,542,000 | +10.2% | 95,993 | -7.5% | 0.01% | +14.3% |
Q2 2020 | $3,214,000 | +11.0% | 103,758 | -1.1% | 0.01% | -12.5% |
Q1 2020 | $2,896,000 | +1.9% | 104,900 | +8.0% | 0.01% | +33.3% |
Q4 2019 | $2,842,000 | – | 97,173 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,612,363 | $55,014,000 | 24.06% |
PERKINS CAPITAL MANAGEMENT INC | 155,550 | $5,307,000 | 3.58% |
First Light Asset Management, LLC | 763,907 | $26,065,000 | 1.87% |
Bullseye Asset Management LLC | 108,054 | $3,617,000 | 1.44% |
Ranger Investment Management | 756,380 | $25,808,000 | 1.41% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,006,088 | $34,328,000 | 1.21% |
EMERALD ADVISERS, LLC | 885,436 | $30,211,000 | 1.12% |
Granite Investment Partners, LLC | 963,187 | $32,864,000 | 0.96% |
Nicholas Investment Partners, LP | 428,378 | $14,616,000 | 0.92% |
Redwood Investments, LLC | 335,054 | $11,432,000 | 0.90% |